Preview

Cardiovascular Therapy and Prevention

Advanced search

Sleep characteristics in obesity

Abstract

Aim. To study sleep disturbance role in obesity pathogenesis among co-morbidity-free patients.
Material and methods. The study included 66 co-morbidity-free obese patients and 24 healthy volunteers. All participants underwent detailed clinical examination. Psychometrical scales for subjective self-assessment were used: subjective sleep disturbance assessment scale, hospital anxiety and depression scale; vegetative disturbance scale. Somnological function was assessed by polysomnography method.
Results. Sleep pathology in obesity was registered in 86% of the patients, including 59% with sleep respiratory disturbances (RD) and typical complaints: poor quality of morning wake-up, morning headache, daytime somnolence. Falling asleep process, sleep continuity, and total sleep length were unchanged, but deep stages of slow-wave sleep (stages 3 and 4) and fast sleep phase (FSP) were deficient. In 27% of the patients, sleep RD were absent, with premature wake-ups as a typical complaint. Objectively, total sleep time reduction, falling asleep and intra-sleep vigilance time increase, sleep structure disturbance, mostly due to frequent wake-ups, decrease of deep stage slow-wave sleep and FSP were observed. No subjective or objective sleep quality disturbances were registered in 14% of the patients.
Conclusion. In complex obesity treatment, differential sleep pathology correction is important, including RD management and adequate psycho-pathology therapy.

About the Authors

O. V. Lubshina
Moscow State Medico-Stomatological University
Russian Federation


A. L. Vertkin
Moscow State Medico-Stomatological University
Russian Federation


Ya. I. Levin
City Clinical Hospital № 81, Moscow
Russian Federation


References

1. Бутрова С.А. Сибутрамин (Меридиа) в лечении ожирения: опыт применения в России, Клин фармак тер 2001; 10(2): 55-8.

2. Левин Я.И., Посохов С.И., Ханунов И.Г. Ночной сон и депрессия. Соврем психиат 1998; 3: 23 c.

3. Полуэктов М.Г. Ожирение и сон. В кн.: Ожирение. Под ред. И.И.Дедова, Г.А.Мельниченко. Москва «Медицинское информ агентство» 2001; 272-312.

4. Bitz C, Helle H, A Astrup. A Paradoxical Diurnal Movement Pattern in Obese Subjects With Type 2 Diabetes. Diabetes Care 2005; 28: 2040-1.

5. Bliwise D, Feldman D, Bliwise N, et al. Risk factors for sleepdisordered breathing in heterogeneous geriatric populations. Am J Geriatr Society 1987; 35: 132-41.

6. Cooper BG, White J, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995; 18(3): 172-9.

7. Drenick EJ, Bales GS. Excessive mortality and causes of death in morbidly obese men. JAVA 1980; 243: 443-5.

8. Grunstein RR. Metabolic aspects of sleep apnea. Sleep 1996; 19(10): 218-20.

9. Grunstein RR, Handelsman DJ, Lawrence SJ, et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989; 68: 352-8.

10. Guilleminault C. Upper Airway Resistance Syndrome, Insomnia, and Functional Somatic Syndromes. Chest 2003; 123: 12-4.

11. Lugaresi E, Cirignotta E, Montagna P, Sforza E. Snoring: pathogenic, clinical and therapeutic aspects. In: Principles and Practice of Sleep Medicine: 2nd ed. Philadelphia: Harcourt Brace & Company 1994; 621-9.

12. Redwine L, Hauger RL, Gillin СJ, Irwin M. Effects of sleep and sleep deprivation in interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000; 85: 3597-603.

13. Saini J, Krieger J, Brandenberger G, et al. Continuous positive airway pressure treatment: Effects on grouth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993; 25: 375-81.

14. Seidell JS. The worldwide epidemic of obesity. In: Progress in obesity research. 8-th International cjngress of obesity. B.Guy-Grand, G.Ailhaud. eds London. 1999; 47-53.

15. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.

16. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function and sleep. Sleep 1996; 19: 221-4.


Review

For citations:


Lubshina O.V., Vertkin A.L., Levin Ya.I. Sleep characteristics in obesity. Cardiovascular Therapy and Prevention. 2007;6(1):73-78. (In Russ.)

Views: 1019


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)